_________________________________________

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 2, 2017

 

 

START SCIENTIFIC, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

 

Delaware 000-52227 20-4910418
(State of Other Jurisdiction (Commission File (IRS Employer
Of Incorporation) Number) Identification No.)

 

521 Wilshire Blvd., Suite 101

Oklahoma City, OK

 

73116

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (210) 758-5898

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[ ] Written communications pursuant to Rule 425 under the Securities Act

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

 

 
 

 

Item 5.01 Changes in Control of Registrant.

 

On November 2, 2017, Norris R. Harris, the Company’s controlling shareholder sold and assigned all 100 shares of Series A Preferred Stock (the “Control Stock”) of Start Scientific, Inc. (the “Company”) to OmniElite Holdings LLC (“OmniElite”), and OmniElite’s controlling shareholder Steven Lawrence Brickner for $35,000. The Control Stock is not convertible into common stock but collectively hold 1,000,000,000 voting rights, which amount represents 75.60% of the vote. The Control Stock is entitled to vote together with holders of common stock on all such matters upon which common stockholders may vote. As a result, Mr. Brickner and OmniElite now hold a controlling beneficial interest in the Company and may unilaterally determine the election of the Board and other substantive matters requiring approval of the Company’s stockholders.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Start Scientific, Inc.
     
     
Date:  November 3, 2017   By:  /s/ Jim Frazier ________
    Jim Frazier
    Chief Executive Officer